Papers by Matthew R Weir · AgingResearch.News

Kidney3602 Oct
Variation in Living Donor Evaluation and Acceptance across the United States
Cohort study of 1,888 peoplePopulations
Paper
Kidney International23 Sep
Results from the Phase 2 Explore-CKD Trial of lorundrostat, a novel aldosterone synthase inhibitor, in participants with uncontrolled hypertension, chronic kidney disease, and albuminuria
Trial in peopleInterventions
Paper
Advances in Therapy23 Sep
Comparative Effectiveness of Once-Weekly Semaglutide Versus Sulfonylureas, DPP4 Inhibitors, and Thiazolidinediones in Patients with Type 2 Diabetes and Chronic Kidney Disease
Cohort study in peopleSemaglutide
Paper
Kidney3604 Sep
Metformin-Associated Lactic Acidosis and Relative Euglycemic Ketoacidosis Precipitated by a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report and Literature Review
Interventions
Paper

AHA Scientific Sessions 2025 Abstract3 Nov
Association Between Individual Social Determinants of Health and Incident PAD: A CRIC Study
Study in peoplePopulations
Paper
ADA Scientific Sessions 2025 Abstract13 Jun
Changes in Clinical Measures in U.S. Adults with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD) Who Received Once-Weekly (OW) Semaglutide
Study in peopleInterventions
Paper
ADA Scientific Sessions 2025 Abstract13 Jun
Changes in Clinical Measures among U.S. Adults with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD) Receiving Once-Weekly Semaglutide (sema OW) vs. Oral Antidiabetic Medications (ADMs)
Study in peopleInterventions
Paper